N-(4-chlorophenylcarbamoyl)-4-nitrophenylsulfonamide | 128924-53-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(4-chlorophenylcarbamoyl)-4-nitrophenylsulfonamide
• 英文别名: 1-(4-Chlorophenyl)-3-(4-nitrophenyl)sulfonylurea
• CAS: 128924-53-8
• 化学式: C₁₃H₁₀ClN₃O₅S
• 分子量: 355.759
• InChiKey: QHVAOXCESICALD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  130
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  4-(dimethylamino)-N-((4-nitrophenyl)sulfonyl)pyridin-1-ium-1-carbimidate 、 对氯苯胺 在 盐酸 作用下， 以 乙腈 、 甲醇 、 水 为溶剂， 反应 1.0h， 以42%的产率得到N-(4-chlorophenylcarbamoyl)-4-nitrophenylsulfonamide
  参考文献：
  名称：

  Synthesis of Novel Aryl(heteroaryl)sulfonyl Ureas of Possible Biological Interest

  摘要：

  发现芳基和杂芳基磺酰胺与碳酸二苯酯 (DPC) 和 4-二甲基氨基吡啶 (DMAP) 的反应过程取决于所用磺酰胺的 pKa。 pKa ~ 10 的芳基磺酰胺得到 4-二甲氨基-吡啶鎓芳基磺酰基-氨基甲酰基化物，而酸性更强的杂芳基磺酰胺 (pKa ~ 8) 则得到 4-二甲氨基吡啶鎓杂芳基磺酰基氨基甲酸酯。氨基甲酰基和氨基甲酸盐均与脂肪族和芳香族胺反应，形成适当的芳基（杂芳基）磺酰基脲，因此可以被视为危险且难以处理的芳基（杂芳基）磺酰基异氰酸酯的安全稳定的替代品。

  DOI：

  10.3390/molecules15031113

文献信息

• Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationships
  作者：J. Jeffry Howbert、C. Sue Grossman、Thomas A. Crowell、Brent J. Rieder、Richard W. Harper、Kenneth E. Kramer、Eddie V. Tao、James Aikins、Gerald A. Poore

  DOI：10.1021/jm00171a013

  日期：1990.9

  A series of diarylsulfonylureas with exceptionally broad-spectrum activity against syngeneic rodent solid tumors in vivo is described. Their discovery resulted from a program dedicated to in vivo screening for novel oncolytics in solid tumor models, rather than traditional ascites leukemia models. The structures, oral efficacy, side-effect profile, and mechanism of action of these sulfonylureas appear to be distinct from previously known classes of oncolytics. An extensive series of analogues was prepared to probe structure-activity relationships (SAR), with particular focus on the substituent patterns of each aryl domain. Quantitative analysis of these substituent SARs, using the method of cluster significance analysis, showed the lipophilicity of the substituents to be the dominant determinant of activity. One compound from the series, LY186641 (104, sulofenur), has progressed to Phase I clinical trials as an antitumor drug.
• HOWBERT, J. JEFFRY;GROSSMAN, C. SUE;CROWELL, THOMAS A.;RIEDER, BRENT J.;H+, J. MED. CHEM., 33,(1990) N, C. 2393-2407
  作者：HOWBERT, J. JEFFRY、GROSSMAN, C. SUE、CROWELL, THOMAS A.、RIEDER, BRENT J.、H+

  DOI：——

  日期：——
• Synthesis of Novel Aryl(heteroaryl)sulfonyl Ureas of Possible Biological Interest
  作者：Franciszek Sączewski、Anna Kuchnio、Monika Samsel、Marta Łobocka、Agnieszka Kiedrowska、Karolina Lisewska、Jarosław Sączewski、Maria Gdaniec、Patrick J. Bednarski

  DOI：10.3390/molecules15031113

  日期：——

  The course of reaction of aryl and heteroaryl sulfonamides with diphenylcarbonate (DPC) and 4-dimethylaminopyridine (DMAP) was found to depend on the pKa of the sulfonamide used. Aryl sulfonamides with pKa ~ 10 gave 4-dimethylamino-pyridinium arylsulfonyl-carbamoylides, while the more acidic heteroaryl sulfonamides (pKa ~ 8) furnished 4-dimethylaminopyridinium heteroarylsulfonyl carbamates. Both the carbamoylides and carbamate salts reacted with aliphatic and aromatic amines with the formation of appropriate aryl(heteroaryl)sulfonyl ureas, and therefore, can be regarded as safe and stable substitutes of the hazardous and difficult to handle aryl(heteroaryl)sulfonyl isocyanates.

  发现芳基和杂芳基磺酰胺与碳酸二苯酯 (DPC) 和 4-二甲基氨基吡啶 (DMAP) 的反应过程取决于所用磺酰胺的 pKa。 pKa ~ 10 的芳基磺酰胺得到 4-二甲氨基-吡啶鎓芳基磺酰基-氨基甲酰基化物，而酸性更强的杂芳基磺酰胺 (pKa ~ 8) 则得到 4-二甲氨基吡啶鎓杂芳基磺酰基氨基甲酸酯。氨基甲酰基和氨基甲酸盐均与脂肪族和芳香族胺反应，形成适当的芳基（杂芳基）磺酰基脲，因此可以被视为危险且难以处理的芳基（杂芳基）磺酰基异氰酸酯的安全稳定的替代品。